Humacyte, Inc. - HUMA Sales Growth YoY (TTM)

Brandmark of humacyte.com (HUMA)

The year-over-year (TTM) commercial revenue growth trend clearly demonstrates the market position of Humacyte, Inc. (HUMA), where 52.50 is the current value of the indicator. Growth is supported by unique patents for bioengineered tissues, which create a powerful barrier to entry for competitors. Leadership in reproductive medicine is driven by investments in the synthesis of vessels outside the body. However, success depends on regulatory approval and the adoption of these technologies by physicians.

HUMA Humacyte Sales Growth YoY (TTM) (02/11/2024 - 11/15/2026)

Humacyte Inc. - analytical breakdowns and key metrics (HUMA)

- stock quotes and analyst forecast:
Price Performance Chart Humacyte, Inc.|HUMA - Consensus Target
- issuer market value details:
Market Capitalization Humacyte Inc|HUMA - Total Company Value
- book value of equity indicators:
Accounting Value per Share Humacyte|HUMA - Book Capitalization|Market Capitalization to Book Value Ratio humacyte.com|HUMA - Company Total Assets
- debt level and financial liquidity data:
Total Debt to Equity Ratio Humacyte, Inc.|HUMA - Long-Term Debt to Equity Ratio|Current Liabilities to Capital Humacyte Corp|HUMA - Company Total Debt|Debt to Book Capital Humacyte, Inc.|HUMA - Company Long-Term Debts|Short-Term Debt Humacyte|Intermediate Coverage Ratio humacyte.com
- earnings and multiples data:
HUMA - Net Profit|Company Profit Forecast Humacyte, Inc.|HUMA - Price to Earnings Ratio|Price to Future Earnings Ratio Humacyte, Inc.|HUMA - PEG Multiple|Enterprise Value to EBITDA Ratio Humacyte Corp|HUMA - Operating profit before deduction of amortization|Net earnings per share for the last four quarters Humacyte|HUMA - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months humacyte.com|HUMA - Net earnings per share growth this year|Earnings growth forecast for next year Humacyte, Inc.
- sales revenue and business income indicators:
HUMA - Company Revenue|Company Future Sales Volume Humacyte Corp|HUMA - P/S Multiple|Forward P/S Multiple Humacyte Inc|HUMA - Sales Growth YoY (Last Twelve Months)
Fundamental company valuation:Humacyte Corp HUMA
Mass-produced product of Humacyte Corp

The stability of the Humacyte, Inc. (HUMA) business model depends on scaling the implementation of bioengineered vessels within military medicine and clinics for blood flow restoration. An analysis of the YoY commercial revenue dynamics over the LTM allows for an assessment of the annual percentage growth in income, identifying trend inflection points and the company's ability to overcome logistical barriers. A slowdown in this chart signals product implementation issues, warning investors of a potential risk of price correction.

Who Humacyte, Inc. competes with

NTRA: Sales Growth YoY (Last 12 Months)|Sera Prognostics Inc. - Sales Growth YoY (TTM)